Press Releases ASEP Medical Holdings Inc.

Equities

ASEP

CA04368A1057

Delayed Canadian Securities Exchange Other stock markets 11:18:02 2024-05-01 am EDT			5-day change	1st Jan Change
0.2 ^CAD	0.00%		+48.15%	-2.44%

Feb. 28	Asep Medical Says Its Sepsis Diagnostic Technology Can Provide Improved Odds for Pediatric Appendicitis	MT
Jan. 26	ASEP Medical Holdings Inc. announced that it expects to receive CAD 1.5 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Asep Medical Holdings Inc. to Hold Significant Investor Information Webinar this Friday, March 22, 2024, at 4 pm EST	Mar. 18	AQ
Asep Medical Confirms the Use of AI - Enables Improved Treatments for Common Biofilm Infections and Rapid Sepsis Diagnostics	Mar. 13	AQ
Asep Medical's Sepsis Diagnostic Technology Can Provide Improved Odds for Pediatric Appendicitis	Feb. 27	AQ
ASEP INC. ANNOUNCES CLOSING OF DEBT SETTLEMENT	Dec. 28	AQ
ASEP INC. ANNOUNCES CLOSING OF THE FIRST TRANCHE OF LIFE OFFERING	Dec. 20	AQ
ASEP ANNOUNCES CREDIT FACILITY, DEBT SETTLEMENT AND AMENDED OFFERING DOCUMENT	Dec. 18	AQ
ASEP ANNOUNCES PRIVATE PLACEMENT OF UP TO $2 MILLION	Nov. 30	AQ
Asep Medical Holdings Inc. is Granted Patent Approval for its AI-based Sepsis Diagnostic Technology in the US	Nov. 24	AQ
Asep Medical Holdings Inc. Signs Joint Venture Agreement with Leading Chinese Medical Diagnostics Company Sansure Biotech Inc.	Nov. 21	AQ
Asep Inc. Obtains Exclusive Worldwide License from the University of British Columbia for Ground-breaking Medical Device Coating Technology	23-07-31	AQ
Another Breakthrough-- Asep Inc.'s A.I.-Based Sepsis Technology Identifies COVID-19 Severity from a Blood Sample	23-07-14	AQ
ASEP MEDICAL HOLDINGS INC. ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS AND PROVIDES CORPORATE UPDATE	23-07-07	AQ
Asep Inc. Receives Grant from NanoMedicines Innovation Network (NMIN), Funded by the Government of Canada	23-06-23	AQ
Asep Inc. Founder, Chair and CEO, Dr. Robert E. W. Hancock, Ranked 4th Best Microbiologist in the World	23-06-20	AQ
Asep Inc. Undertakes Final Steps Toward NASDAQ Listing	23-06-16	AQ
Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa	23-06-09	AQ
Asep Inc. Announces Ground-breaking A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies	23-06-02	AQ
Asep Inc. Appoints General Wesley Clark (Ret.), David Johnson, J. Bernard Rice, Dr. Islam Mohamed and Thomas O'Shaughnessy to its Advisory Board and Dr. Rob Stenstrom, as Medical Director	23-03-06	AQ
ASEP MEDICAL HOLDINGS INC. ANNOUNCES ADOPTION OF LONG-TERM PERFORMANCE INCENTIVE PLAN, GRANT OF STOCK OPTIONS	23-01-20	AQ
Asep Inc. Signs Letter of Intent for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa	23-01-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ASEP Medical Holdings Inc.

Equities

ASEP

CA04368A1057

Press Releases

Filters